ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Virginia » Neurology

Top Neurology Prescribers in Virginia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
PETER PUZIO D.O.

Neurology

2,646

$574K

260
174 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 2%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 26%

$217
Average prescription price

Avg: $241

KERMIT LLOYD M.D.

Neurology

2,628

$1.26M

356
196 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 26%

$480
Average prescription price

Avg: $241

SUSAN BROWN MD

Neurology

2,596

$482K

341
232 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 26%

$186
Average prescription price

Avg: $241

SHUBHANGI CHUMBLE M.D.

Neurology

2,576

$647K

380
242 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 26%

$251
Average prescription price

Avg: $241

EUGENE MADONIA

Neurology

2,561

$263K

234
146 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 26%

$103
Average prescription price

Avg: $241

MRUGENDRA PATEL M.D.

Neurology

2,553

$183K

270
152 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 26%

$72
Average prescription price

Avg: $241

MUBASHIR KHAN MD

Neurology

2,546

$556K

286
179 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 26%

$219
Average prescription price

Avg: $241

OCTAVIO DEMARCHENA

Neurology

2,492

$574K

334
217 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 26%

$230
Average prescription price

Avg: $241

ROBERT MCMAHON MD

Neurology

2,472

$615K

251
196 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 26%

$249
Average prescription price

Avg: $241

ROBERT WHITE M.D.

Neurology

2,406

$784K

309
196 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

4%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 26%

$326
Average prescription price

Avg: $241

PATRICK CAPONE MD

Neurology

2,381

$789K

260
178 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 26%

$332
Average prescription price

Avg: $241

JOHN WITTMAN M.D.

Neurology

2,209

$538K

302
193 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 26%

$244
Average prescription price

Avg: $241

RICHARD ERWIN M.D.

Neurology

2,189

$499K

216
142 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 26%

$228
Average prescription price

Avg: $241

JOSEPH HOGAN M.D.

Neurology

2,168

$424K

258
141 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 26%

$196
Average prescription price

Avg: $241

PATRICK HARDING MD

Neurology

2,158

$563K

294
184 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 26%

$261
Average prescription price

Avg: $241

IBRAHIM HEGAB MD

Neurology

2,146

$362K

147
56 are 65+

19%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 26%

$169
Average prescription price

Avg: $241

ZACK PERDUE M.D.

Neurology

2,140

$379K

176
92 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 26%

$177
Average prescription price

Avg: $241

GEORGE STERGIS MD

Neurology

2,135

$308K

228
163 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 26%

$144
Average prescription price

Avg: $241

GREGORY COOPER M.D.

Neurology

2,053

$718K

217
159 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

41%
prescriptions for brand name drugs

Avg: 26%

$350
Average prescription price

Avg: $241

NEIL CROWE MD

Neurology

2,045

$565K

193
115 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 26%

$276
Average prescription price

Avg: $241

MANUEL MARRUFO M.D.

Neurology

2,030

$203K

256
160 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 26%

$100
Average prescription price

Avg: $241

KAMEL BEN-OTHMANE MD

Neurology

1,970

$267K

296
154 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 26%

$136
Average prescription price

Avg: $241

MARK LANDRIO M.D.

Neurology

1,964

$447K

254
171 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 26%

$228
Average prescription price

Avg: $241

SUSANNA MATHE M.D.

Neurology

1,960

$795K

251
158 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

39%
prescriptions for brand name drugs

Avg: 26%

$405
Average prescription price

Avg: $241

JOSEPH HARRIS M.D.

Neurology

1,909

$457K

213
115 are 65+

18%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 26%

$240
Average prescription price

Avg: $241

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank